Cite
Levetiracetam as the first-line treatment for neonatal seizures: a systematic review and meta-analysis
MLA
Robert Hooper, et al. “Levetiracetam as the First-Line Treatment for Neonatal Seizures: A Systematic Review and Meta-Analysis.” Developmental Medicine and Child NeurologyREFERENCES, vol. 63, no. 11, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d10ed151290262d4e3d4cc0c5f100b93&authtype=sso&custid=ns315887.
APA
Robert Hooper, Adarsh Bhulani, Rachael M Wahid, Prakash Satodia, & Viraraghavan Vadakkencherry Ramaswamy. (2021). Levetiracetam as the first-line treatment for neonatal seizures: a systematic review and meta-analysis. Developmental Medicine and Child NeurologyREFERENCES, 63(11).
Chicago
Robert Hooper, Adarsh Bhulani, Rachael M Wahid, Prakash Satodia, and Viraraghavan Vadakkencherry Ramaswamy. 2021. “Levetiracetam as the First-Line Treatment for Neonatal Seizures: A Systematic Review and Meta-Analysis.” Developmental Medicine and Child NeurologyREFERENCES 63 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d10ed151290262d4e3d4cc0c5f100b93&authtype=sso&custid=ns315887.